ABSTRACT, Site-specific mutagenesis of the blood vesselinducing protein angiogenin has been used to further explore both its homology to pancreatic ribonuclease and the functional roles of particular residues. Replacement of Asp-116 in angiogenin by either asparagine (D116N), alanine (D116A)f or histidine (D116H) markedly enhances both its ribonucleolytic activity and angiogenic potency. Activity toward tRNA is -8-, 15-, and 18-fold greater than native angiogenin for D116N-, D116A-, and.D116H-angiogenin, respectively. The enzymatic specificity of angiogenin, however, has been maintained. Thus, cleavage of 18S and 28S rRNA by the most active His-116 mutant yields-the same pattern of polynucleotide products as from angiogenin, whereas there are only minor alterations in activity with cytidylyl(3',5')adenosine and uridylyl(3',5')-adenosine. Extensive biological assays on the chicken embryo chorioallantoic membrane demonstrate that D116H-angiogenin is one to two orders ofmagnitude more potent in inducing neovascularization than native angiogenin, which correlates well with enhanced enzymatic action. These results support the proposition that the enzymatic and angiogenic activities on angiogenin are interrelated.
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An intriguing feature of the blood vessel-inducing protein angiogenin (1) is its striking structural similarity with mammalian pancreatic RNases. Overall, there is 35% sequence identity between human RNase and human angiogenin (2) . Conserved residues include not only those involved directly in RNase catalysis-His-12, Lys-41, and His-119-but those thought to be important for substrate recognition-e.g., Gln-11, Thr-45, Glu-111, and Ser-123. Indeed, angiogenin is a ribonucleolytic enzyme (3) and appears to use the same array of catalytic residues as RNase (4) . Despite these similarities, however, their enzymatic and biological actions differ dramatically. While angiogenin does not readily act upon conventional RNase substrates such as nucleoside 2',3'-cyclic monophosphates or poly(C), it does catalyze the limited cleavage of rRNA as well as tRNA (3, 4) . Angiogenin readily abolishes protein synthesis in vitro by specific cleavage of the 18S subunit of intact ribosomes, whereas with RNase, inhibition of protein synthesis is a result of general rRNA degradation (5) . Moreover, angiogenin binds 60-fold more tightly to placental ribonuclease inhibitor than does bovine RNase A (6). Unlike angiogenin, RNase is neither angiogenic nor does it stimulate phospholipase C-mediated formation of diacylglycerol in endothelial cells (7) .
The availability of mammalian (8) and Escherichia coli (9) recombinant expression systems for angiogenin has made it possible to begin defining in detail the structural features in angiogenin responsible for its diverse functions. Thus, sitespecific mutagenesis has been initiated to further explore the angiogenin/RNase homology and the role of particular residues in function. This approach is both complementary with the chemical modification studies already performed on the protein (4) One such residue is Asp-121, which is conserved in all known pancreatic RNases (10) . In the RNase crystal structure, the carboxylate side chain of Asp-121 forms a hydrogen bond with NT of His-119 (11) (12) (13) , suggesting that it may orient the imidazole ring of His-119 during catalysis, a postulate yet to be examined in detail.
The present study explores the involvement of Asp-116 the corresponding residue in angiogenin-in both enzymatic and angiogenic activity using site-specific mutagenesis. Replacement of this residue by asparagine, alanine, or histidine markedly enhances the ribonucleolytic activity and angiogenic potency of angiogenin, supporting a critical link between its enzymatic action and angiogenesis.
MATERIALS AND METHODS Materials. The E. coli expression vector pAng2, containing a synthetic angiogenin gene, was prepared as described (9) . This vector contains a modified trp promoter and an ampicillin-resistance marker for selection.
Site-Specific Mutagenesis. pAng2 was digested with Kpn I and EcoRI, the angiogenin coding sequence was ligated into phage M13mpl8 containing compatible ends, and the singlestrand M13 DNA was isolated using standard procedures. Mutagenesis of Asp-116 in angiogenin was done by using the method of Kunkel (14) employing a Muta-Gene in vitro mutagenesis kit (Bio-Rad). The oligonucleotide pGTCCATC-TAVMWCAGTCTATC (where V represents adenine, guanine, or cytosine; M represents cytosine or adenine; and W represents thymine or adenine), which codes for nine possible amino acids at the position of Asp-116, was used. Mutant DNAs were identified by dideoxynucleotide chain-termination DNA sequencing using modified T7 DNA polymerase (15) (United States Biochemical, Cleveland). DoubleAbbreviations: CpA, cytidylyl(3',5')adenosine; UpA, uridylyl(3', 5')adenosine. *Angiogenin produced in E. coli differs from the authentic protein only with respect to its N-terminal residue: Met-(-1) versus pyroglutamic acid-i. This difference has no effect on either ribonucleolytic or angiogenic activity (9) . For simplicity, bacterially produced Met-(-1) angiogenin will be referred to as angiogenin.
The nomenclature for angiogenin mutants is as follows: D116H-angiogenin, Asp-116 -. His; D116A-angiogenin, Asp-116 -. Ala; and D116N-angiogenin, Asp-116 -. Asn.
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stranded M13mpl8 DNA for each mutant was digested with Kpn I and EcoRI, and the angiogenin insert was ligated into gel-purified E. coli expression plasmid as described (9) . After transformation into W3110 cells (ATCC 27325), the expression levels of six to eight individual colonies were assessed by immunoblotting using affinity-purified rabbit antiangiogenin before large-scale expression (9) .
Expression and Purification of Mutant Proteins. Methods for expression of recombinant angiogenin (see footnote following Abbreviations) in E. coli and purification of the protein have been described in detail (9) . Peak fractions after C18 HPLC were dialyzed against water before testing for angiogenic and ribonucleolytic activity and were devoid of endotoxin.
Structural Characterization of Angiogenic Mutants. Amino acid analysis was performed as described (2) . For peptide mapping, 0.7-1.5 nmol of protein was digested at 37°C with trypsin (1 ,ug). Peptides were purified by reverse-phase HPLC (9) .
Assays. Activity toward tRNA was determined using a precipitation assay as described (4) except that incubations were for 2-2.5 hr. In experiments where the tRNA concentration was varied, reaction mixtures were adjusted to tRNA at 0.35 mg/ml immediately before addition of perchloric acid. Activity toward HT-29 rRNA (18S and 28S) was assessed by agarose gel electrophoresis (3). Activity toward cytidylyl-(3',5')adenosine (CpA) and uridylyl(3',5')adenosine (UpA) was determined using a sensitive HPLC method (3) as described (9) . Enzyme concentrations were determined by amino acid analysis.
Angiogenic activity was assessed on the chicken embryo chorioallantoic membrane using the method of Knighton et al. (16) as described (1) .
RESULTS
Preparation of Angiogenin Mutants. A mixture of oligonucleotides, coding for nine different amino acids at the position of Asp-116 in angiogenin, was used for mutagenesis. DNA sequencing of M13 clones identified three mutants of particular interest-the asparagine mutant or D116N-angiogenin, the alanine mutant or D116A-angiogenin, and the histidine mutant or D116H-angiogenin. Each mutant DNA was sequenced in its entirety to rule out any spurious mutations.
Mutant and unmodified proteins were expressed in E. coli and purified to homogeneity using established procedures (9) . Final preparations were judged >98% pure by NaDodSO4/ PAGE (data not shown).
Structural Characterization of Angiogenin Mutants. Extensive structural characterization was done on each mutant protein to ensure that there were no unexpected structural changes and that the three disulfide bonds (2) had formed correctly. The amino acid compositions of the mutant proteins (Table 1) are consistent with that expected based on the replacement made and the primary structure of angiogenin (2) .
Tryptic digests were performed on each of the mutant proteins, and the resultant peptides were fractionated by C18 HPLC. The peptides isolated account for all but two residues of angiogenin (Arg-32 and Arg-33) and include the three disulfide-bonded peptides T-9, T-10, and T-11 (9 Analyses were carried out as described (2) . Relative molar amounts of amino acids are given. In parentheses are the numbers of residues expected based on the amino acid sequence of angiogenin.
peptide T-11 from unaltered angiogenin is consistent with this change. Thus, these data indicate both that the three disulfide bonds have formed correctly and that changes in primary structure are limited to residue 116.
Ribonucleolytic Activity of Angiogenin Mutants. Alterations in ribonucleolytic activity of Asp-116 mutants of angiogenin were examined using a variety of substrates. All three mutant enzymes are significantly more active toward tRNA than is angiogenin itself (Fig. 1). D116N -, D116A-, and D116H-angiogenin are 8-, 15-, and 18-fold more active than angiogenin, respectively.
The activity of D116H-angiogenin toward HT-29 rRNA at pH 7.0 was compared with that of angiogenin. Incubation of rRNA (1.2 mg/ml) with 0.7 tLM angiogenin for 60 min generated polynucleotide cleavage fragments ranging from 100 to 500 nucleotides in length as assessed by agarose gel min, the major polynucleotide products characteristic of the action of angiogenin on rRNA are not degraded significantly.
The activities of angiogenin and mutant enzymes toward the dinucleoside phosphates CpA and UpA were also determined (Table 3 ) using an extremely sensitive HPLC method for quantitation of substrate and cleavage products (3, 9) . The kcat/Km values of D116H-and D116A-angiogenin toward CpA at pH 6.0 are increased 3.7-fold and 1.7-fold, respectively, whereas that of D116N-angiogenin is actually decreased by 40%. With UpA, similar trends in relative activity are noted, but the kcat/Km values are lower than with CpA by at least a factor of 10. At pH 7.5, the activities of D116A-angiogenin and angiogenin toward CpA are lower by about a factor of 10 than at pH 6 (Table 3) . Thus, in contrast with the markedly enhanced activity of the mutant enzymes toward tRNA and rRNA, only minor alterations in transphosphorylation rates are observed with dinucleoside phosphate substrates.
Dependence on pH and Substrate Concentration. Fig. 2 compares the pH profiles for D116A-, D116H-, and D116N-angiogenin with that of the native enzyme using tRNA as substrate. The optimum seen with Ala-116 and Asn-116 angiogenin is near pH 7 and is virtually indistinguishable from that of unaltered angiogenin. Moreover, the shapes of the profiles are similar. In contrast, the optimum for D116H-angiogenin is shifted to about pH 7.4 and is somewhat broader.
The dependence of activity on tRNA concentration was examined with D116A-angiogenin (Fig. 3) to assess whether the increased activity is due to enhanced substrate binding or turnover. The concentration of D116A-angiogenin used was Biological Activity of D116H-Angiogenin. The angiogenic activity of D116H-angiogenin was examined using the chorioallantoic membrane assay (Table 4) . Angiogenin produces at least 50% positive angiogenic responses at 1 ng per egg, but activity drops sharply below this level (Table 4 and ref. 1). In contrast, two independent preparations of D116H-angiogenin consistently produce 58% positive responses at 0.5 ng per egg and greater than 40% positive responses at 5 pg per egg. These data indicate an increase in angiogenic potency for the His-116 mutant of one to two orders of magnitude.
DISCUSSION
Anfinsen (17) first showed that residues at the C terminus of RNase are involved in its function; treatment with pepsin removes the C-terminal tetrapeptide of RNase (Asp-121-Val-124), resulting in markedly diminished catalytic activity. Semisynthetic RNases (18, 19) were subsequently used to examine the functional roles of various residues near the C terminus, including Asp-121, which is fully conserved (20) (21) (22) . Its replacement by asparagine decreases catalysis by a factor of 20 but does not significantly change substrate binding for cytidine 2',3'-cyclic monophosphate (22) . A hydrogen bond between the p-carboxylate of Asp-121 and the imidazole of His-119 in crystal structures of both RNase bound to a substrate analogue (11) and the free enzyme (12, 13) bond, placing the Nff of His-119 within hydrogen bonding distance of the substrate phosphate group (23) . While such considerations imply a key functional role for Asp-121 in RNase action, this role remains to be established.
In the present study, the functional role of Asp-116 in angiogenin-the residue corresponding to Asp-121 in RNase-was examined by site-specific mutagenesis. A preliminary three-dimensional structure of angiogenin (24) has indicated that the side chain of this residue is close to His-114 (His-119 in RNase) to which it might be hydrogen bonded. Mutants were chosen to allow evaluation of the importance of any specific hydrogen bond without introducing large alterations in structure. Thus, mutation to an isosteric asparagine residue removes the P-carboxylate but retains the possibility for hydrogen bonding. The second replacement, histidine, also is capable of hydrogen bonding and, in addition, acquires a positive charge at low pH. Mutation to alanine, however, entirely removes hydrogen bonding capacity and creates a cavity likely to be occupied by a water molecule.
Based on the above conjectures regarding possible Asp-121 functions in RNase, replacement of Asp-116 in angiogenin might have been expected to affect catalytic activity negatively. Surprisingly, the ribonucleolytic activity of all three of the angiogenin mutants toward tRNA is enhanced significantly-that of the histidine mutant most of all (Fig. 1) .
It was important to establish whether the increase in activity reflected an alteration of the characteristic ribonucleolytic activity of angiogenin in terms of its substrate specificity (3) . With 18S and 28S rRNA as substrate, D116H-angiogenin generates the same pattern of polynucleotide products produced by angiogenin, but the concentration of enzyme required to achieve cleavage is lower by a factor of 15 . As with native angiogenin, these products are largely resistant to further degradation, even after extended incubation with enzyme concentrations more than an order of magnitude higher than that required to generate the cleavage pattern. It was also possible, of course, that with more conventional RNase substrates, such as CpA and UpA, there would be a similar increase in activity. This appears not to be the case. With D116H-and D116A-angiogenin, activity toward CpA increases only 3.7-to 1.8-fold and that of the Asn-116 mutant is actually only 60% compared to native angiogenin (Table 3) . Thus, mutagenesis of Asp-116 to histidine, alanine, and asparagine markedly enhances the specific ribonucleolytic activity of angiogenin without substantially altering its activity toward dinucleoside phosphates.
The chemical basis for the enhanced activity of the mutant enzymes remains to be defined. However, activity measurements over a range of tRNA concentrations indicate that the increased effectiveness is almost entirely due to enhanced substrate turnover, and there are no large differences in pH optimum for the asparagine and alanine mutant enzymes. Thus, mutation of Asp-116 could result in a reorganization of the side chain of His-114 and water structure associated with it, thereby placing the imidazole ring in a more favorable position for catalysis. In particular, the removal of a hydrogen bonding network of water molecules associated with His-114 could decrease the energy required to form the transition state for transphosphorylation. It is not clear why this catalytic advantage is not fully manifested with dinucleoside phosphate substrates. If more reactive substrates for angiogenin become available, it would be important to examine mechanistic aspects of this modified activity in greater detail.
The mechanism by which angiogenin induces neovascularization in vivo is not known at present. However, the availability of mutant proteins with altered enzymatic properties provides a means to identify the structural features requisite for angiogenesis while also further establishing relationships between ribonucleolytic and angiogenic activity. Extensive biological assays on the chicken embryo chorioallantoic membrane show that replacement of Asp-116 in angiogenin by histidine significantly increases angiogenic potency (Table 4) . Thus, while the activity of native angiogenin drops sharply below 1 ng per egg, 58% of the responses to D116H-angiogenin are still positive at 0.5 ng per egg, and the mutant has significant activity even at 5 pg per egg. This increase in potency of one to two orders of magnitude correlates well with the increase in specific activity toward RNA and strikingly extends previous indications that the angiogenic activity of angiogenin is related to its specific ribonucleolytic action (3, 25) . It should be noted that modification of active-site histidine residues of angiogenin abolishes not only its angiogenic and enzymatic activities but also its capacity to activate endothelial cell phospholipase C (7) .
A number of seemingly obvious questions remain unanswered. Why has Asp-121 in RNase been maintained throughout evolution? Does it play a crucial catalytic role? Are the present data with angiogenin directly relevant to RNase? Indeed, is RNase an extremely efficient catalyst because it has found a means to utilize Asp-121 to advantage? Further mutations to explore the structure and mechanism of angiogenin and RNase will likely provide insight into both the importance of other conserved residues and the significance of the RNase homology to the characteristic action of angiogenin.
